Andere Sprachen BioNTech SE Börse Stuttgart

Aktien

A2PSR2

US09075V1026

22UA

Markt geschlossen - Börse Stuttgart Andere Börsenplätze 21:31:08 17.06.2024			Nachbörslich 21:59:17
82.75 ^EUR	-4.28%		82.45	-0.36%

20:01	Sektor-Update: Aktien des Gesundheitswesens geben im Nachmittagshandel nach	MT
18:11	Top Midday Stories: Nvidia erhält SCOTUS-Überprüfung der Krypto-Verkaufsklage; Apple-Zulieferer entwickelt Material für Festkörperbatterien; OpenAI startet angeblich medizinisches KI-Tool; Walt Disneys 'Inside Out 2' setzt größten Start des Jahres 2024 an; IQVentures will Aaron's aufkaufen	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Sector Update: Health Care Stocks Ease in Afternoon Trading	20:01
Top Midday Stories: Nvidia Gets SCOTUS Review of Crypto Sales Lawsuit; Apple Supplier Develops Material for Solid-State Batteries; OpenAI Reportedly Launches Medical AI Tool; Walt Disney's 'Inside Out 2' Sets Biggest Opening of 2024; IQVentures to Acquire Aaron's	18:11
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading	17:15
BioNTech Says US FDA Placed Partial Clinical Hold on Cancer Drug Trial	16:10
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug	14:32
BioNTech : INFORMATION INCLUDED AS PART OF THIS FORM 6 K Form 6 K	13:22
BioNTech : ASCO 2024	14.06.
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading	11.06.
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading	10.06.
Indonesia ramps up fight against tuberculosis amid concerns on economic impact	10.06.
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	05.06.
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say	05.06.
BioNTech : ASCO 2024	03.06.
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading	03.06.
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)	01.06.
Genmab A/S and Biontech SE Announce Initial Data from the Phase 2 Gct1046-04 Trial (NCT05117242) Evaluating Acasunlimab	01.06.
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)	01.06.
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower	31.05.
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP	31.05.
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	30.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

BioNTech SE: Schrottniveau-Bewertung

Am 22. März 2024 um 10:52 Uhr

BIONTECH : Ein Fehlschlag ist ein Fehlschlag

Am 21. März 2024 um 14:27 Uhr